Literature DB >> 7679141

Buspirone in progressive myoclonus epilepsy.

M R Pranzatelli, D Franz, E Tate, J M Martens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7679141      PMCID： PMC1014783          DOI： 10.1136/jnnp.56.1.114

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing.

Authors:  P Trouillas; F Brudon; P Adeleine
Journal:  Arch Neurol       Date:  1988-11

Review 2.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

3.  Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy.

Authors:  W Löscher; S J Czuczwar
Journal:  Neurosci Lett       Date:  1985-09-30       Impact factor: 3.046

4.  Transient effect of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies: clinical and electrophysiological study.

Authors:  M Koskiniemi; M Hyyppä; K Sainio; T Salmi; S Sarna; L Uotila
Journal:  Epilepsia       Date:  1980-08       Impact factor: 5.864
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.